General Information of Disease (ID: DISOWG27)

Disease Name Myopathy
Disease Class FB32-FB3Z: Muscle disorder
Definition
A disease of the muscle in which the muscle fibers do not function properly. This results in muscular weakness.|Editor note: TODO check this, relationship to myotonic disorder/syndrome, also check HP definition
Disease Hierarchy
DISXAP3G: Muscle tissue disorder
DISR9DGU: Skeletal muscle disorder
DISOWG27: Myopathy
ICD Code
ICD-11
ICD-11: 8C7Y
Expand ICD-11
'8C7Y
Disease Identifiers
MONDO ID
MONDO_0005336
MESH ID
D009135
UMLS CUI
C0026848
MedGen ID
10135
HPO ID
HP:0003198
SNOMED CT ID
129565002

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
UX-001 DMD2O0L Phase 3 Small molecular drug [1]
DEX-M74 DMKWXF3 Phase 1/2 NA [2]
GNE Lipoplex DMURO94 Phase 1 NA [3]
NPC-09 DMY3TAE Phase 1 Small molecular drug [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 70 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CLCN1 TTUYAF3 Limited Altered Expression [5]
DGAT1 TT0GV3R Limited Biomarker [6]
GNE TT4DP5S Limited Genetic Variation [7]
OPA1 TTTU49Q Limited Biomarker [8]
RBCK1 TTIKUVC Limited Genetic Variation [9]
C1QBP TTWTD7F moderate Biomarker [10]
CSF3 TT5TQ2W moderate Biomarker [11]
ORAI1 TTE76YK moderate Genetic Variation [12]
PAK2 TT279WO moderate Biomarker [13]
PYGM TTZHY6R moderate Genetic Variation [14]
ADCY5 TTN64VU Strong Genetic Variation [15]
ALB TTFNGC9 Strong Therapeutic [16]
AOC3 TT7HC21 Strong Biomarker [17]
ARG1 TT7ZQEV Strong Biomarker [18]
CACNA1S TT94HRF Strong Genetic Variation [19]
CLN3 TTORF9W Strong Biomarker [20]
CNTN1 TTPR8FK Strong Genetic Variation [21]
COL6A3 TT5WCAH Strong Genetic Variation [22]
CTSB TTF2LRI Strong Biomarker [23]
CYP3A4 TTWP7HQ Strong Biomarker [24]
DDX5 TTZKPVC Strong Biomarker [25]
DNM2 TTVRA5G Strong Genetic Variation [26]
EIF2AK4 TT9U4EP Strong Biomarker [18]
FABP3 TT3TGLR Strong Biomarker [27]
FDXR TT3W4IX Strong Biomarker [28]
FECH TTQ6VF4 Strong Biomarker [29]
FGF21 TTQ916P Strong Biomarker [30]
FHL1 TTI7ENL Strong Genetic Variation [31]
FST TTDNM9W Strong Biomarker [32]
G6PC TTBQMJ8 Strong Biomarker [33]
GFAP TTI6FFX Strong Genetic Variation [34]
HEXIM1 TTFOKAH Strong Altered Expression [35]
HMGCR TTPADOQ Strong Biomarker [36]
HSPB8 TTY0OJN Strong Genetic Variation [37]
HTR3B TTR6K75 Strong Biomarker [38]
HTR7 TTO9X1H Strong Biomarker [38]
INS TTZOPHG Strong Biomarker [39]
KCNJ2 TTH7UO3 Strong Genetic Variation [40]
LAMP2 TTULDG7 Strong Genetic Variation [41]
MAOA TT3WG5C Strong Biomarker [42]
MBNL2 TTH9OLG Strong Biomarker [43]
MSTN TTM8I2X Strong Biomarker [44]
MTM1 TTY2TCU Strong Biomarker [45]
MUSK TT6SA0X Strong Biomarker [46]
MYBPC3 TT9WOBN Strong Genetic Variation [47]
MYH2 TTBIL13 Strong Biomarker [48]
PCSK9 TTNIZ2B Strong Genetic Variation [49]
POLA1 TTGPJ0U Strong Biomarker [50]
PPARA TTJ584C Strong Biomarker [51]
PPIF TTRFQTB Strong Biomarker [52]
PRKCD TT7A1BO Strong Biomarker [53]
PRKCH TTONI0R Strong Biomarker [54]
PRKCZ TTBSN0L Strong Biomarker [54]
PRNP TTY5F9C Strong Biomarker [55]
RYR1 TTU5CIX Strong Biomarker [56]
SCN4A TT84DRB Strong Genetic Variation [57]
SETD7 TTJ0FSU Strong Biomarker [58]
SGCA TTS9Q5V Strong Genetic Variation [59]
SGCG TTSMT9W Strong Biomarker [60]
SLC25A4 TTU5A6Q Strong Genetic Variation [61]
SLK TT8K4DE Strong Biomarker [62]
SMN1 TT8QL6X Strong Altered Expression [63]
SQSTM1 TTOT2RY Strong Altered Expression [64]
TARDBP TT9RZ03 Strong Biomarker [65]
TNNI3 TTNLDK6 Strong Biomarker [66]
UTRN TTNO1VA Strong Biomarker [67]
XDH TT7RJY8 Strong Therapeutic [68]
CUL3 TTPCU0Q Definitive Biomarker [69]
HNRNPA1 TTPJ9XK Definitive Biomarker [70]
HNRNPA2B1 TT8UPW6 Definitive Biomarker [70]
------------------------------------------------------------------------------------
⏷ Show the Full List of 70 DTT(s)
This Disease Is Related to 3 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC22A5 DT3HUVD Strong Genetic Variation [71]
SLC25A5 DTL1TRY Strong Genetic Variation [61]
SLC7A10 DTVL2JY Definitive Biomarker [72]
------------------------------------------------------------------------------------
This Disease Is Related to 5 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
AOC2 DE8DP90 Strong Biomarker [17]
FXN DEXVHDB Strong Genetic Variation [73]
HINT1 DEWJATF Strong Biomarker [74]
PGM1 DEA3VM1 Strong Biomarker [75]
SULT1A3 DEP7E8X Strong Genetic Variation [76]
------------------------------------------------------------------------------------
This Disease Is Related to 227 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACADS OTGFANYQ Limited Biomarker [77]
ACADVL OT50L4XB Limited Genetic Variation [78]
AGL OTWBM7WY Limited Altered Expression [79]
CAP2 OTC1WFNO Limited Biomarker [80]
CFDP1 OTXY7J96 Limited Genetic Variation [81]
CFL2 OTE2W0DH Limited Biomarker [82]
COL6A6 OT4MVGRW Limited Autosomal recessive [83]
COX1 OTG3O9BN Limited Genetic Variation [84]
COX3 OTNNGBYJ Limited Genetic Variation [85]
CPT2 OTIN6G20 Limited Genetic Variation [86]
DPAGT1 OTYEJAGZ Limited Genetic Variation [87]
EIF4G2 OTEO98CR Limited Genetic Variation [81]
FKTN OTQ9GCXL Limited Biomarker [88]
GEMIN4 OTX7402E Limited Genetic Variation [81]
GFER OTVK43OK Limited Genetic Variation [89]
HNRNPDL OTB3BFCV Limited Biomarker [90]
LDB3 OTGQL1AM Limited Altered Expression [91]
LPIN2 OTRRTMXX Limited Biomarker [6]
MORC3 OT81NKVT Limited Biomarker [92]
MYO18B OTGYY4NK Limited Biomarker [93]
MYOT OTCEW5XW Limited Biomarker [94]
NEB OT7P9IR3 Limited Biomarker [95]
PGAM2 OT9BE03I Limited Genetic Variation [96]
PIK3R4 OTRL8QP8 Limited Biomarker [97]
PLEC OTU4XDEG Limited Biomarker [98]
POLG OTDUCT04 Limited Genetic Variation [99]
PRKAG2 OTHTAM54 Limited Biomarker [100]
PSMD2 OT6HZHN7 Limited Genetic Variation [81]
STIM1 OT8CLQ1W Limited Genetic Variation [101]
SYNM OTOI8TRJ Limited Altered Expression [102]
TCAP OTQQMJ94 Limited Biomarker [103]
TPM1 OTD73X6R Limited Genetic Variation [104]
TRAPPC11 OTPZYXGA Disputed Biomarker [105]
ACTN2 OT9FOLD7 moderate Genetic Variation [106]
AMPD1 OTU17BCI moderate Biomarker [107]
B4GALT1 OTBCXEK7 moderate Biomarker [108]
BIN1 OTK8O0X8 moderate Genetic Variation [109]
CCDC174 OTA0Z9RZ moderate Genetic Variation [110]
CDSN OTQW4HV6 moderate Altered Expression [111]
COL6A2 OTQC6PPO moderate Genetic Variation [112]
CRPPA OTC85K8Q moderate Biomarker [88]
DTNA OTVBIRH2 moderate Biomarker [113]
GFPT1 OTQBDO45 moderate Genetic Variation [114]
MEGF10 OTILSPJ6 moderate Biomarker [115]
MYPN OTHTOFDU moderate Genetic Variation [116]
PERM1 OTZJW04C moderate Biomarker [117]
PFKM OT1QY9JM moderate Genetic Variation [118]
PRH1 OTQZ6HX0 moderate Biomarker [119]
PTRH2 OTBU39Q1 moderate Genetic Variation [120]
RAPSN OTGMSWDQ moderate Biomarker [121]
RIPOR2 OTXB6LIR moderate Altered Expression [122]
SMAD4 OTWQWCKG moderate Biomarker [123]
TNNI2 OTGGZFSC moderate Biomarker [124]
AARS2 OTOB0KSG Strong Biomarker [125]
ABHD5 OTY829Z3 Strong Genetic Variation [6]
ACAD9 OT4HITJ6 Strong Genetic Variation [126]
ACTA1 OTOVGLPG Strong Biomarker [127]
ACTC1 OTJU04B1 Strong Altered Expression [128]
ACTN3 OT9DZ7JQ Strong Genetic Variation [129]
ADARB1 OTGKSZEV Strong Biomarker [130]
ADSS1 OTF6FE38 Strong Biomarker [131]
AGFG1 OTI8ZKC4 Strong Biomarker [132]
AIFM1 OTKPWB7Q Strong Genetic Variation [133]
AMPH OTWPGWZX Strong Genetic Variation [134]
ANO5 OTOW8R6H Strong Genetic Variation [135]
APOBEC2 OT4CCS0Q Strong Biomarker [136]
ATP2A1 OT959A3A Strong Genetic Variation [137]
ATP6 OTPHOGLX Strong Genetic Variation [138]
BCAP31 OTKSACR4 Strong Biomarker [139]
BEST1 OTWHE1ZC Strong Genetic Variation [140]
BICD2 OTVJ03NZ Strong Genetic Variation [141]
CALD1 OTNJKJ6Q Strong Biomarker [139]
CAPN3 OTCHG3YK Strong Genetic Variation [142]
CASQ1 OTAY8WOO Strong Genetic Variation [143]
CAV3 OTWSFDB4 Strong Genetic Variation [144]
CAVIN1 OTFO915U Strong Biomarker [145]
CAVIN4 OTB1DM2C Strong Biomarker [146]
CCDC78 OTWZVF89 Strong Genetic Variation [147]
CD109 OTDADBM4 Strong Biomarker [50]
CD2AP OTC76KQM Strong Biomarker [148]
CDCP1 OTD7RRWK Strong Genetic Variation [149]
CDK5RAP1 OTDEJXD0 Strong Biomarker [150]
CELF1 OT6JQ5RS Strong Altered Expression [151]
CHCHD10 OTCDHAM6 Strong Genetic Variation [152]
CHD7 OTHNIZWZ Strong Biomarker [153]
CHMP1B OTP715L8 Strong Genetic Variation [154]
CHST14 OT3FLH7U Strong Biomarker [155]
CLP1 OTPY965Y Strong Altered Expression [35]
CNNM1 OTHRSSGH Strong Altered Expression [35]
COL12A1 OTHLTV53 Strong Genetic Variation [156]
COL4A1 OTL6D1YE Strong Genetic Variation [157]
COL6A1 OTYKSCOB Strong Biomarker [158]
COL9A2 OT1ZBDBV Strong Genetic Variation [159]
COLEC12 OTIQTK9G Strong Altered Expression [35]
COX2 OTTMVBJJ Strong Genetic Variation [160]
COX4I1 OTU0FC24 Strong Biomarker [161]
COX4I2 OTB98B21 Strong Biomarker [161]
CSRP3 OTECBJMV Strong Biomarker [162]
CYTB OTAHB98A Strong Genetic Variation [163]
DDX20 OT6G8YF3 Strong Altered Expression [63]
DGUOK OT78HUZB Strong Genetic Variation [164]
DNA2 OT4DJFFU Strong Genetic Variation [165]
DNAH8 OTGES2OU Strong Genetic Variation [81]
DNAJB2 OTZHPV5M Strong Altered Expression [166]
DNAJB6 OTMHIIAN Strong Genetic Variation [167]
DOK7 OTR2V7HO Strong Biomarker [141]
DPYS OTLTUIVL Strong Genetic Variation [168]
EIF3A OTFABY9G Strong Biomarker [50]
EMD OTR8ZANE Strong Biomarker [169]
EVC2 OTY0M5SD Strong Genetic Variation [149]
EYS OT0NBPL5 Strong Genetic Variation [170]
FAM111B OT9IQ9NV Strong Genetic Variation [171]
FBXO32 OTUE978R Strong Biomarker [172]
FDX2 OT4KF6Q5 Strong Genetic Variation [173]
FKRP OTMUZ7GH Strong Biomarker [88]
FLNC OT3F8J6Y Strong Biomarker [174]
FRG1 OTEJ8HSD Strong Biomarker [175]
FXR1 OTEMQ1SR Strong Genetic Variation [176]
FYCO1 OTKZHTZ5 Strong Biomarker [177]
GATAD2B OTJL128N Strong Biomarker [25]
GBE1 OTK2N05B Strong Genetic Variation [178]
GFM2 OT51TIMY Strong Altered Expression [179]
GLRX5 OTE3L48D Strong Biomarker [180]
GYG1 OT9PU6I2 Strong Biomarker [181]
GYS1 OTJZJRWK Strong Genetic Variation [182]
HADHB OT4Y1I62 Strong Genetic Variation [183]
HARS1 OTHOEOTS Strong Biomarker [184]
HARS2 OTC8X3H9 Strong Biomarker [184]
IBA57 OT9SPG2X Strong Genetic Variation [185]
IGFALS OTTWCZYM Strong Biomarker [186]
IGHMBP2 OTAZFPF5 Strong Genetic Variation [187]
IREB2 OT747D24 Strong Biomarker [29]
ISCU OTSW6DQP Strong Biomarker [188]
ITGA7 OTTBTAYW Strong Biomarker [189]
KIF21A OT511XD9 Strong Genetic Variation [190]
KLF10 OT4F4UGS Strong Altered Expression [191]
KLF15 OTGMQMVR Strong Biomarker [192]
KY OTK1L8VX Strong Biomarker [193]
LAMA1 OTQZMP86 Strong Altered Expression [194]
LAMA2 OTFROQWE Strong Biomarker [195]
LMCD1 OT3AWE8O Strong Altered Expression [196]
LMNA OT3SG7ZR Strong Genetic Variation [197]
LMO7 OTDLY6TC Strong Genetic Variation [43]
LPIN1 OTQ75KF2 Strong Genetic Variation [198]
LTBP4 OTC8WL2V Strong Biomarker [199]
MATR3 OTESJ5S7 Strong Genetic Variation [200]
MBNL1 OTOV7J85 Strong Biomarker [201]
MICU1 OTS7N0LE Strong Biomarker [202]
MPV17 OT579DMU Strong Biomarker [203]
MRRF OT6AHPVG Strong Altered Expression [179]
MSTO1 OT37XCNP Strong Genetic Variation [204]
MTMR14 OTUUEY6Q Strong Biomarker [205]
MTMR2 OTNCYGBP Strong Altered Expression [206]
MYBPC1 OTRPN93S Strong Genetic Variation [207]
MYBPC2 OTCXSB6A Strong Biomarker [208]
MYH3 OTOCCGEB Strong Genetic Variation [209]
MYH6 OT3YNCH1 Strong Biomarker [210]
MYH8 OT9F350W Strong Biomarker [211]
MYL12B OTXMLQOT Strong Genetic Variation [212]
MYL2 OT78PC0C Strong Genetic Variation [212]
MYL9 OT6B22JB Strong Genetic Variation [212]
MYO6 OTJQYRC7 Strong Biomarker [210]
MYOD1 OTV2S79X Strong Biomarker [213]
MYOG OTPLJKFA Strong Altered Expression [214]
NARS2 OTL5X535 Strong Genetic Variation [215]
NFU1 OTL58QZS Strong Genetic Variation [216]
OBSCN OTT14OVX Strong Biomarker [217]
OBSL1 OT6M8M3J Strong Biomarker [218]
OPTN OT2UXWH9 Strong Biomarker [219]
PABPN1 OT3MC5SE Strong Biomarker [220]
PACC1 OTKBS8CC Strong Genetic Variation [221]
PAX7 OTDMQRPO Strong Altered Expression [222]
PCBP1 OTHN0TD7 Strong Biomarker [223]
PDLIM5 OTLQVV22 Strong Genetic Variation [224]
PGK1 OT6V1ICH Strong Genetic Variation [225]
PHKA1 OTLPQCRF Strong Genetic Variation [226]
PHOX2A OTVS3R2X Strong Biomarker [227]
PIK3C2A OTFBU4GD Strong Altered Expression [228]
PKD1L2 OTVDFDED Strong Biomarker [229]
PNPLA2 OTR3ERMR Strong Genetic Variation [230]
POLD3 OTEQEFQ2 Strong Biomarker [25]
POLG2 OTDBMZJB Strong Genetic Variation [231]
PPP1R14C OTZ3F6D2 Strong Genetic Variation [149]
PRPF6 OT3U0ABN Strong Genetic Variation [61]
PYROXD1 OTPGO23E Strong Biomarker [232]
QDPR OTSKOIUX Strong Biomarker [233]
RPL30 OTLQVY1Z Strong Biomarker [234]
RPL5 OTM8EBRI Strong Biomarker [234]
RYR3 OT4EHIP4 Strong Genetic Variation [235]
SAMD4A OT4MKCC8 Strong Altered Expression [151]
SECISBP2 OTBXUURJ Strong Genetic Variation [236]
SELENON OTSGKO5M Strong Genetic Variation [237]
SENP5 OTN9Q07Y Strong Biomarker [238]
SFTPA1 OT87XL1U Strong Biomarker [239]
SIL1 OTDI85I5 Strong Genetic Variation [240]
SLN OTERIU75 Strong Altered Expression [241]
SMCHD1 OTBV52DR Strong Biomarker [242]
SMN2 OT54RLO1 Strong Altered Expression [63]
SNRPN OTQB1ID1 Strong Altered Expression [63]
SPTAN1 OT6VY3A3 Strong Altered Expression [243]
SPTB OT1Q9ABM Strong Biomarker [244]
SPTBN4 OTAJAVP9 Strong Biomarker [245]
SRGAP3 OT9ZS72C Strong Biomarker [246]
STAC3 OTPY3BGK Strong Genetic Variation [247]
SULT1A4 OTHJ8WWV Strong Genetic Variation [76]
SUN1 OTIU8V4U Strong Biomarker [248]
SUN2 OT2IQJUC Strong Genetic Variation [248]
SYNE1 OTSBSLUH Strong Biomarker [249]
TFAM OTXXV5V7 Strong Biomarker [8]
TK2 OTS1V4XB Strong Biomarker [250]
TMEM126B OT8JJ5TP Strong Genetic Variation [251]
TMEM43 OTM9RS9G Strong Biomarker [252]
TMEM70 OTLTKYXG Strong Genetic Variation [253]
TNNT1 OT8PBOAR Strong Biomarker [254]
TNPO3 OTOT3HH0 Strong Genetic Variation [255]
TNXB OTVBWAV5 Strong Biomarker [256]
TPM3 OT5RU5G6 Strong Biomarker [257]
TRIM32 OTJOV0PG Strong Genetic Variation [76]
TRIM54 OTI49DD6 Strong Genetic Variation [258]
TRIM63 OTUSWA74 Strong Genetic Variation [259]
TRIM72 OTFAFXPC Strong Biomarker [260]
ACTN1 OTUCLNXH Definitive Biomarker [69]
COL4A2 OTJK1LKN Definitive Genetic Variation [261]
MYF6 OTLLMHMI Definitive Genetic Variation [262]
RPL3 OTX6VXLB Definitive Biomarker [72]
TRIP4 OTA8OASA Definitive Biomarker [72]
TTN OT0LZ058 Definitive Genetic Variation [263]
------------------------------------------------------------------------------------
⏷ Show the Full List of 227 DOT(s)

References

1 ClinicalTrials.gov (NCT01830972) An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid (ER Tablets + IR Capsules) in Patients With GNE Myopathy. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02346461) An Open Label Phase 2 Study of DEX-M74 in Subjects With GNE Myopathy. U.S. National Institutes of Health.
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034673)
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4644).
5 Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.J Physiol. 2019 Mar;597(5):1361-1381. doi: 10.1113/JP277123. Epub 2019 Jan 30.
6 Inborn errors of cytoplasmic triglyceride metabolism.J Inherit Metab Dis. 2015 Jan;38(1):85-98. doi: 10.1007/s10545-014-9767-7. Epub 2014 Oct 10.
7 Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion.Muscle Nerve. 2019 Jul;60(1):98-103. doi: 10.1002/mus.26486. Epub 2019 Apr 29.
8 Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology.J Biol Chem. 2006 Dec 8;281(49):37972-9. doi: 10.1074/jbc.M606059200. Epub 2006 Sep 26.
9 Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum.J Neurol. 2018 Feb;265(2):394-401. doi: 10.1007/s00415-017-8710-x. Epub 2017 Dec 19.
10 Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies. Am J Hum Genet. 2017 Oct 5;101(4):525-538. doi: 10.1016/j.ajhg.2017.08.015. Epub 2017 Sep 21.
11 Efficacy and the Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Muscular Dystrophy: A Non-Randomized Clinical Trial.Front Neurol. 2017 Oct 26;8:566. doi: 10.3389/fneur.2017.00566. eCollection 2017.
12 ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.J Physiol. 2019 Jan;597(2):561-582. doi: 10.1113/JP277079. Epub 2018 Nov 28.
13 Late-onset megaconial myopathy in mice lacking group I Paks.Skelet Muscle. 2019 Feb 21;9(1):5. doi: 10.1186/s13395-019-0191-4.
14 Novel variant in the PYGM gene causing late-onset limb-girdle myopathy, ptosis, and camptocormia.Muscle Nerve. 2018 Jan;57(1):157-160. doi: 10.1002/mus.25588. Epub 2017 Mar 21.
15 ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.Parkinsonism Relat Disord. 2017 Aug;41:37-43. doi: 10.1016/j.parkreldis.2017.05.004. Epub 2017 May 10.
16 Clofibrate, nephrotic syndrome, and histological changes in muscle.Lancet. 1973 Jun 9;1(7815):1326. doi: 10.1016/s0140-6736(73)91351-2.
17 Overexpression of semicarbazide-sensitive amine oxidase in human myopathies.Muscle Nerve. 2004 Feb;29(2):261-6. doi: 10.1002/mus.10550.
18 Arginine deficiency causes runting in the suckling period by selectively activating the stress kinase GCN2.J Biol Chem. 2011 Mar 18;286(11):8866-74. doi: 10.1074/jbc.M110.216119. Epub 2011 Jan 14.
19 RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.Pharmacogenomics. 2018 Nov;19(16):1235-1249. doi: 10.2217/pgs-2018-0106. Epub 2018 Oct 16.
20 Autophagic vacuolar myopathy is a common feature of CLN3 disease.Ann Clin Transl Neurol. 2018 Oct 14;5(11):1385-1393. doi: 10.1002/acn3.662. eCollection 2018 Nov.
21 Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy. Am J Hum Genet. 2008 Dec;83(6):714-24. doi: 10.1016/j.ajhg.2008.10.022. Epub 2008 Nov 20.
22 Two novel COL6A3 mutations disrupt extracellular matrix formation and lead to myopathy from Ullrich congenital muscular dystrophy and Bethlem myopathy spectrum.Gene. 2018 Sep 25;672:165-171. doi: 10.1016/j.gene.2018.06.026. Epub 2018 Jun 9.
23 Endogenous cathepsin B inhibitor activity in normal and myopathic red and white skeletal muscle.Muscle Nerve. 1982 Apr;5(4):313-20. doi: 10.1002/mus.880050407.
24 Interaction potential between clarithromycin and individual statins-A systematic review.Basic Clin Pharmacol Toxicol. 2020 Apr;126(4):307-317. doi: 10.1111/bcpt.13343. Epub 2019 Nov 8.
25 Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5.Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8041-5. doi: 10.1073/pnas.1422273112. Epub 2015 Jun 15.
26 Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.Sci Rep. 2019 Feb 7;9(1):1580. doi: 10.1038/s41598-018-38184-0.
27 Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers.Toxicol Sci. 2008 Jun;103(2):382-96. doi: 10.1093/toxsci/kfn042. Epub 2008 Feb 27.
28 A common missense variant of LILRB5 is associated with statin intolerance and myalgia.Eur Heart J. 2017 Dec 21;38(48):3569-3575. doi: 10.1093/eurheartj/ehx467.
29 Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery.Blood. 2010 Jan 28;115(4):860-9. doi: 10.1182/blood-2009-09-243105. Epub 2009 Nov 25.
30 Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21-SIRT1-AMPK-PGC1 Pathway.J Cell Physiol. 2017 Jul;232(7):1893-1906. doi: 10.1002/jcp.25735. Epub 2017 Jan 5.
31 Muscle death participates in myofibrillar abnormalities in FHL1 knockout mice.Biochem Biophys Res Commun. 2020 Feb 26;523(1):105-111. doi: 10.1016/j.bbrc.2019.12.026. Epub 2019 Dec 10.
32 Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease.Sci Rep. 2019 Aug 6;9(1):11392. doi: 10.1038/s41598-019-47818-w.
33 Gene therapy for glycogen storage diseases.Hum Mol Genet. 2019 Oct 1;28(R1):R31-R41. doi: 10.1093/hmg/ddz133.
34 The MyoRobot technology discloses a premature biomechanical decay of skeletal muscle fiber bundles derived from R349P desminopathy mice.Sci Rep. 2019 Jul 24;9(1):10769. doi: 10.1038/s41598-019-46723-6.
35 The atypical calpains: evolutionary analyses and roles in Caenorhabditis elegans cellular degeneration.PLoS Genet. 2012;8(3):e1002602. doi: 10.1371/journal.pgen.1002602. Epub 2012 Mar 29.
36 Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.Neuromuscul Disord. 2019 Jul;29(7):543-548. doi: 10.1016/j.nmd.2019.05.007. Epub 2019 May 23.
37 Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathy.Eur J Neurol. 2018 Jan;25(1):154-163. doi: 10.1111/ene.13478. Epub 2017 Dec 2.
38 Physiogenomic association of statin-related myalgia to serotonin receptors. Muscle Nerve. 2007 Sep;36(3):329-35. doi: 10.1002/mus.20871.
39 Insulin-induced weakness in hypokalemic myopathy.Ann Neurol. 1979 Aug;6(2):139-40. doi: 10.1002/ana.410060216.
40 Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome.J Biol Chem. 2003 Dec 19;278(51):51779-85. doi: 10.1074/jbc.M310278200. Epub 2003 Oct 1.
41 Lysosome-associated membrane protein-2 deficiency increases the risk of reactive oxygen species-induced ferroptosis in retinal pigment epithelial cells.Biochem Biophys Res Commun. 2020 Jan 8;521(2):414-419. doi: 10.1016/j.bbrc.2019.10.138. Epub 2019 Oct 28.
42 Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. FASEB J. 2005 Aug;19(10):1359-61.
43 Altered chromosomal positioning, compaction, and gene expression with a lamin A/C gene mutation.PLoS One. 2010 Dec 14;5(12):e14342. doi: 10.1371/journal.pone.0014342.
44 Reduced serum myostatin concentrations associated with genetic muscle disease progression.J Neurol. 2017 Mar;264(3):541-553. doi: 10.1007/s00415-016-8379-6. Epub 2017 Jan 10.
45 Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Due to MTMR2 Mutations and Implications in Membrane Trafficking.Front Neurosci. 2019 Oct 14;13:974. doi: 10.3389/fnins.2019.00974. eCollection 2019.
46 Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence. Eur J Hum Genet. 2015 Sep;23(9):1151-7. doi: 10.1038/ejhg.2014.273. Epub 2014 Dec 24.
47 Association of 25 bp deletion in MYBPC3 gene with left ventricle dysfunction in coronary artery disease patients.PLoS One. 2011;6(9):e24123. doi: 10.1371/journal.pone.0024123. Epub 2011 Sep 7.
48 Clinical remission of myopathy with MYH2 deficiency after precision medicine-developed rehabilitation: a case report.Am J Transl Res. 2018 Nov 15;10(11):3827-3832. eCollection 2018.
49 Successful treatment of a patient with statin-induced myopathy and myotonic dystrophy type II with proprotein convertase subtilisin/kexin type 9 inhibitor, alirocumab (Praluent).J Clin Lipidol. 2017 Nov-Dec;11(6):1485-1487. doi: 10.1016/j.jacl.2017.08.014. Epub 2017 Sep 4.
50 Deficiency of a 180-kDa extracellular matrix protein in Fukuyama type congenital muscular dystrophy skeletal muscle.Neuromuscul Disord. 2002 Feb;12(2):117-20. doi: 10.1016/s0960-8966(01)00251-6.
51 Bezafibrate induces myotoxicity in human rhabdomyosarcoma cells via peroxisome proliferator-activated receptor alpha signaling. Toxicol In Vitro. 2010 Feb;24(1):154-9. doi: 10.1016/j.tiv.2009.08.001. Epub 2009 Aug 13.
52 Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice.Hum Mol Genet. 2009 Jun 1;18(11):2024-31. doi: 10.1093/hmg/ddp126. Epub 2009 Mar 17.
53 Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat.Am J Physiol. 1998 Jan;274(1):H295-307. doi: 10.1152/ajpheart.1998.274.1.H295.
54 Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy.Neurology. 2004 May 25;62(10):1778-82. doi: 10.1212/01.wnl.0000125197.70310.8e.
55 Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy.BMC Genomics. 2009 Apr 28;10:201. doi: 10.1186/1471-2164-10-201.
56 An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy.Neurology. 2019 Apr 2;92(14):e1600-e1609. doi: 10.1212/WNL.0000000000007246. Epub 2019 Mar 6.
57 Permanent myopathy caused by mutation of SCN4A Metl592Val: Observation on myogenesis in vitro and on effect of basic fibroblast growth factor on the muscle.Neurosci Bull. 2009 Apr;25(2):61-6. doi: 10.1007/s12264-009-0926-2.
58 Inhibition of Methyltransferase Setd7 Allows the InVitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential.Cell Stem Cell. 2018 Feb 1;22(2):177-190.e7. doi: 10.1016/j.stem.2017.12.010. Epub 2018 Jan 25.
59 Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.Hum Mol Genet. 2008 May 1;17(9):1214-21. doi: 10.1093/hmg/ddn029. Epub 2008 Feb 5.
60 Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping.J Clin Invest. 2015 Nov 2;125(11):4186-95. doi: 10.1172/JCI82768. Epub 2015 Oct 12.
61 Misfolding of mutant adenine nucleotide translocase in yeast supports a novel mechanism of Ant1-induced muscle diseases.Mol Biol Cell. 2015 Jun 1;26(11):1985-94. doi: 10.1091/mbc.E15-01-0030. Epub 2015 Apr 1.
62 Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness.Skelet Muscle. 2017 Feb 2;7(1):3. doi: 10.1186/s13395-016-0119-1.
63 Scurfy Mice Develop Features of Connective Tissue Disease Overlap Syndrome and Mixed Connective Tissue Disease in the Absence of Regulatory T Cells.Front Immunol. 2019 Apr 24;10:881. doi: 10.3389/fimmu.2019.00881. eCollection 2019.
64 Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies.Brain Pathol. 2020 Mar;30(2):261-271. doi: 10.1111/bpa.12772. Epub 2019 Aug 27.
65 ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97.Mol Cell. 2019 May 16;74(4):742-757.e8. doi: 10.1016/j.molcel.2019.03.027. Epub 2019 Apr 9.
66 A graphene oxide/gold nanoparticle-based amplification method for SERS immunoassay of cardiac troponin I.Analyst. 2019 Feb 25;144(5):1582-1589. doi: 10.1039/c8an02022a.
67 Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.Hum Mol Genet. 2014 Feb 1;23(3):618-36. doi: 10.1093/hmg/ddt449. Epub 2013 Sep 18.
68 Lipid peroxidation and changes in cytochrome c oxidase and xanthine oxidase activity in organophosphorus anticholinesterase induced myopathy.J Physiol Paris. 1998 Jun-Aug;92(3-4):157-61. doi: 10.1016/s0928-4257(98)80002-8.
69 Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.JCI Insight. 2019 Apr 16;5(10):e125665. doi: 10.1172/jci.insight.125665.
70 Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis.Neurodegener Dis. 2017;17(6):304-312. doi: 10.1159/000481258. Epub 2017 Nov 11.
71 Clinical and genetic analysis of lipid storage myopathies.Muscle Nerve. 2009 Mar;39(3):333-42. doi: 10.1002/mus.21167.
72 ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy.Ann Neurol. 2020 Feb;87(2):217-232. doi: 10.1002/ana.25660. Epub 2019 Dec 27.
73 Effects of Friedreich's ataxia GAA repeats on DNA replication in mammalian cells.Nucleic Acids Res. 2012 May;40(9):3964-74. doi: 10.1093/nar/gks021. Epub 2012 Jan 19.
74 Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet. 2012 Oct;44(10):1080-3. doi: 10.1038/ng.2406. Epub 2012 Sep 9.
75 Central nervous involvement is common in PGM1-CDG.Mol Genet Metab. 2018 Nov;125(3):200-204. doi: 10.1016/j.ymgme.2018.08.008. Epub 2018 Aug 21.
76 Altered myogenesis and premature senescence underlie human TRIM32-related myopathy.Acta Neuropathol Commun. 2019 Mar 1;7(1):30. doi: 10.1186/s40478-019-0683-9.
77 Short-chain acyl-CoA dehydrogenase gene mutation (c.319C>T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin.Mol Genet Metab. 2008 Feb;93(2):179-89. doi: 10.1016/j.ymgme.2007.09.021. Epub 2007 Dec 3.
78 Clinical features and mutations in seven Chinese patients with very long chain acyl-CoA dehydrogenase deficiency.World J Pediatr. 2014 May;10(2):119-25. doi: 10.1007/s12519-014-0480-2. Epub 2014 May 7.
79 Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy.Endocrinol Metab Clin North Am. 1999 Dec;28(4):801-23. doi: 10.1016/s0889-8529(05)70103-1.
80 CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8397-8402. doi: 10.1073/pnas.1813351116. Epub 2019 Apr 8.
81 A conserved inter-domain communication mechanism regulates the ATPase activity of the AAA-protein Drg1.Sci Rep. 2017 Mar 17;7:44751. doi: 10.1038/srep44751.
82 Expanding the histopathological spectrum of CFL2-related myopathies.Clin Genet. 2018 Jun;93(6):1234-1239. doi: 10.1111/cge.13240. Epub 2018 Mar 25.
83 Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
84 Mitochondrial myopathy due to novel missense mutation in the cytochrome c oxidase 1 gene.J Neurol Sci. 2012 Aug 15;319(1-2):158-63. doi: 10.1016/j.jns.2012.05.003. Epub 2012 May 24.
85 Mutations in mtDNA-encoded cytochrome c oxidase subunit genes causing isolated myopathy or severe encephalomyopathy.Neuromuscul Disord. 2005 Dec;15(12):851-7. doi: 10.1016/j.nmd.2005.09.005. Epub 2005 Nov 8.
86 Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency.Mol Genet Metab. 2018 Apr;123(4):441-448. doi: 10.1016/j.ymgme.2018.02.005. Epub 2018 Feb 12.
87 Tubular Aggregates and Cylindrical Spirals Have Distinct Immunohistochemical Signatures.J Neuropathol Exp Neurol. 2016 Dec;75(12):1171-1178. doi: 10.1093/jnen/nlw096.
88 Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-l-Ribitol Pyrophosphorylase A Muscular Dystrophy.Clin Chem. 2019 Oct;65(10):1295-1306. doi: 10.1373/clinchem.2019.305391. Epub 2019 Aug 2.
89 The disease-associated mutation of the mitochondrial thiol oxidase Erv1 impairs cofactor binding during its catalytic reaction.Biochem J. 2014 Dec 15;464(3):449-59. doi: 10.1042/BJ20140679.
90 HNRNPDL-related muscular dystrophy: expanding the clinical, morphological and MRI phenotypes.J Neurol. 2019 Oct;266(10):2524-2534. doi: 10.1007/s00415-019-09437-3. Epub 2019 Jul 2.
91 Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.Hum Genet. 2006 Nov;120(4):487-99. doi: 10.1007/s00439-006-0228-8. Epub 2006 Aug 23.
92 Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.Clin Rheumatol. 2018 Oct;37(10):2731-2739. doi: 10.1007/s10067-018-4216-x. Epub 2018 Jul 23.
93 Myo18b is essential for sarcomere assembly in fast skeletal muscle.Hum Mol Genet. 2017 Mar 15;26(6):1146-1156. doi: 10.1093/hmg/ddx025.
94 New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses.Acta Neuropathol Commun. 2016 Feb 3;4:8. doi: 10.1186/s40478-016-0280-0.
95 Deleting nebulin's C-terminus reveals its importance to sarcomeric structure and function and is sufficient to invoke nemaline myopathy.Hum Mol Genet. 2019 May 15;28(10):1709-1725. doi: 10.1093/hmg/ddz016.
96 Genomic analysis of five chromosome 7p deletion patients with Greig cephalopolysyndactyly syndrome (GCPS).Eur J Med Genet. 2006 Jul-Aug;49(4):338-45. doi: 10.1016/j.ejmg.2005.10.133. Epub 2005 Nov 28.
97 Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease.EMBO Mol Med. 2013 Jun;5(6):870-90. doi: 10.1002/emmm.201202057. Epub 2013 Apr 30.
98 Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture.Genes Dev. 1997 Dec 1;11(23):3143-56. doi: 10.1101/gad.11.23.3143.
99 Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase mutations.J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):107-10. doi: 10.1136/jnnp-2012-303232. Epub 2012 Aug 29.
100 Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.J Am Coll Cardiol. 2005 Mar 15;45(6):922-30. doi: 10.1016/j.jacc.2004.11.053.
101 Stormorken Syndrome: A Rare Cause of Myopathy With Tubular Aggregates and Dystrophic Features.J Child Neurol. 2019 May;34(6):321-324. doi: 10.1177/0883073819829389. Epub 2019 Feb 14.
102 Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases.Acta Neuropathol. 2003 Jul;106(1):1-7. doi: 10.1007/s00401-003-0695-0. Epub 2003 Apr 1.
103 Rare diagnosis of telethoninopathy (LGMD2G) in a Turkish patient.Neuromuscul Disord. 2017 Sep;27(9):856-860. doi: 10.1016/j.nmd.2017.05.017. Epub 2017 Jun 1.
104 Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies.J Mol Med (Berl). 2000;78(10):543-53. doi: 10.1007/s001090000161.
105 TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of -dystroglycan and muscular dystrophy.Skelet Muscle. 2018 May 31;8(1):17. doi: 10.1186/s13395-018-0163-0.
106 ACTN2 mutations cause "Multiple structured Core Disease" (MsCD). Acta Neuropathol. 2019 Mar;137(3):501-519. doi: 10.1007/s00401-019-01963-8. Epub 2019 Jan 30.
107 Metabolic myopathies discovered during investigations of statin myopathy.Can J Neurol Sci. 2008 Mar;35(1):94-7. doi: 10.1017/s0317167100007630.
108 Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest. 2002 Mar;109(6):725-33. doi: 10.1172/JCI14010.
109 Trouble at the junction: When myopathy and myasthenia overlap.Muscle Nerve. 2019 Dec;60(6):648-657. doi: 10.1002/mus.26676. Epub 2019 Sep 10.
110 CDC174, a novel component of the exon junction complex whose mutation underlies a syndrome of hypotonia and psychomotor developmental delay. Hum Mol Genet. 2015 Nov 15;24(22):6485-91. doi: 10.1093/hmg/ddv357. Epub 2015 Sep 10.
111 X-linked vacuolated myopathy: membrane attack complex deposition on the surface membrane of injured muscle fibers is not accompanied by S-protein.Muscle Nerve. 1998 Jul;21(7):932-5. doi: 10.1002/(sici)1097-4598(199807)21:7<932::aid-mus11>3.0.co;2-s.
112 Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.Pediatr Res. 2018 Dec;84(6):837-841. doi: 10.1038/s41390-018-0206-6. Epub 2018 Oct 18.
113 Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy.Neuromuscul Disord. 2003 Aug;13(6):456-67. doi: 10.1016/s0960-8966(03)00066-x.
114 Novel compound heterozygous GFPT1 mutations in a family with limb-girdle myasthenia with tubular aggregates.Neuromuscul Disord. 2019 Jul;29(7):549-553. doi: 10.1016/j.nmd.2019.05.008. Epub 2019 May 28.
115 The impact of Megf10/Drpr gain-of-function on muscle development inDrosophila.FEBS Lett. 2019 Apr;593(7):680-696. doi: 10.1002/1873-3468.13348. Epub 2019 Mar 12.
116 Recessive MYPN mutations cause cap myopathy with occasional nemaline rods. Ann Neurol. 2017 Mar;81(3):467-473. doi: 10.1002/ana.24900. Epub 2017 Mar 20.
117 Perm1 regulates CaMKII activation and shapes skeletal muscle responses to endurance exercise training.Mol Metab. 2019 May;23:88-97. doi: 10.1016/j.molmet.2019.02.009. Epub 2019 Feb 27.
118 Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease.Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10322-6. doi: 10.1073/pnas.92.22.10322.
119 Myosin Binding Protein-C Slow Phosphorylation is Altered in Duchenne Dystrophy and Arthrogryposis Myopathy in Fast-Twitch Skeletal Muscles.Sci Rep. 2015 Aug 19;5:13235. doi: 10.1038/srep13235.
120 PTRH2 gene mutation causes progressive congenital skeletal muscle pathology.Hum Mol Genet. 2017 Apr 15;26(8):1458-1464. doi: 10.1093/hmg/ddx048.
121 Antirapsyn antibodies in chronic procainamide-associated myopathy (CPAM).Ann N Y Acad Sci. 1998 May 13;841:527-9. doi: 10.1111/j.1749-6632.1998.tb10975.x.
122 Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.FASEB J. 2014 Jul;28(7):2955-69. doi: 10.1096/fj.13-246470. Epub 2014 Mar 31.
123 Smad4 SUMOylation is essential for memory formation through upregulation of the skeletal myopathy gene TPM2.BMC Biol. 2017 Nov 28;15(1):112. doi: 10.1186/s12915-017-0452-9.
124 Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin.Toxicol Sci. 2009 Oct;111(2):402-12. doi: 10.1093/toxsci/kfp166. Epub 2009 Jul 23.
125 AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy.Mol Genet Genomic Med. 2019 Apr;7(4):e00582. doi: 10.1002/mgg3.582. Epub 2019 Jan 31.
126 Severe defect in mitochondrial complex I assembly with mitochondrial DNA deletions in ACAD9-deficient mild myopathy.Muscle Nerve. 2017 Jun;55(6):919-922. doi: 10.1002/mus.25262. Epub 2017 Mar 26.
127 ACTA1-myopathy with prominent finger flexor weakness and rimmed vacuoles.Neuromuscul Disord. 2019 May;29(5):388-391. doi: 10.1016/j.nmd.2019.02.012. Epub 2019 Mar 2.
128 Actin alpha cardiac muscle 1 gene expression is upregulated in the skeletal muscle of men undergoing androgen deprivation therapy for prostate cancer.J Steroid Biochem Mol Biol. 2017 Nov;174:56-64. doi: 10.1016/j.jsbmb.2017.07.029. Epub 2017 Jul 27.
129 ACTN3 R577X Polymorphism Is Associated With the Incidence and Severity of Injuries in Professional Football Players.Clin J Sport Med. 2019 Jan;29(1):57-61. doi: 10.1097/JSM.0000000000000487.
130 Modulation of ADAR mRNA expression in patients with congenital heart defects.PLoS One. 2019 Apr 30;14(4):e0200968. doi: 10.1371/journal.pone.0200968. eCollection 2019.
131 Comparative transcriptome analysis of skeletal muscle in ADSSL1 myopathy.Neuromuscul Disord. 2019 Apr;29(4):274-281. doi: 10.1016/j.nmd.2018.11.003. Epub 2018 Nov 22.
132 Statins and skeletal muscles toxicity: from clinical trials to everyday practice.Pharmacol Res. 2014 Oct;88:107-13. doi: 10.1016/j.phrs.2014.04.012. Epub 2014 May 13.
133 A disease-associated Aifm1 variant induces severe myopathy in knockin mice.Mol Metab. 2018 Jul;13:10-23. doi: 10.1016/j.molmet.2018.05.002. Epub 2018 May 8.
134 Amphiphysin 2 Orchestrates Nucleus Positioning and Shape by Linking the Nuclear Envelope to the Actin and Microtubule Cytoskeleton.Dev Cell. 2015 Oct 26;35(2):186-98. doi: 10.1016/j.devcel.2015.09.018.
135 ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure.Sci Rep. 2019 Aug 8;9(1):11533. doi: 10.1038/s41598-019-47849-3.
136 Apobec2 deficiency causes mitochondrial defects and mitophagy in skeletal muscle.FASEB J. 2018 Mar;32(3):1428-1439. doi: 10.1096/fj.201700493R. Epub 2018 Jan 3.
137 SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers.Mol Genet Metab. 2013 Sep-Oct;110(1-2):162-9. doi: 10.1016/j.ymgme.2013.07.015. Epub 2013 Jul 20.
138 Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography.Nucleic Acids Res. 2000 Oct 15;28(20):E89. doi: 10.1093/nar/28.20.e89.
139 Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23.Am J Hum Genet. 1997 Oct;61(4):909-17. doi: 10.1086/514896.
140 Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophies.Muscle Nerve. 2017 Jul;56(1):117-121. doi: 10.1002/mus.25435. Epub 2017 Feb 3.
141 Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre.Neuromuscul Disord. 2019 Oct;29(10):747-757. doi: 10.1016/j.nmd.2019.08.003. Epub 2019 Aug 19.
142 A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.Brain. 2016 Aug;139(Pt 8):2154-63. doi: 10.1093/brain/aww133. Epub 2016 Jun 3.
143 A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release.PLoS One. 2016 May 19;11(5):e0155516. doi: 10.1371/journal.pone.0155516. eCollection 2016.
144 Coexistence of a CAV3 mutation and a DMD deletion in a family with complex muscular diseases.Brain Dev. 2019 May;41(5):474-479. doi: 10.1016/j.braindev.2019.01.005. Epub 2019 Feb 2.
145 Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations.J Clin Endocrinol Metab. 2019 Mar 1;104(3):957-960. doi: 10.1210/jc.2018-01331.
146 MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes.J Cell Biol. 2009 Jun 29;185(7):1259-73. doi: 10.1083/jcb.200903053. Epub 2009 Jun 22.
147 Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am J Hum Genet. 2012 Aug 10;91(2):365-71. doi: 10.1016/j.ajhg.2012.06.012. Epub 2012 Jul 19.
148 DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.Neuromuscul Disord. 2013 Nov;23(11):883-91. doi: 10.1016/j.nmd.2013.06.002. Epub 2013 Jul 3.
149 Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink.Clin Pharmacol Ther. 2019 Dec;106(6):1353-1361. doi: 10.1002/cpt.1557. Epub 2019 Jul 31.
150 Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and contributes to myopathy in mice and humans.Cell Metab. 2015 Mar 3;21(3):428-42. doi: 10.1016/j.cmet.2015.01.019.
151 Smaug/SAMD4A restores translational activity of CUGBP1 and suppresses CUG-induced myopathy.PLoS Genet. 2013 Apr;9(4):e1003445. doi: 10.1371/journal.pgen.1003445. Epub 2013 Apr 18.
152 In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.Hum Mol Genet. 2018 Jan 1;27(1):160-177. doi: 10.1093/hmg/ddx397.
153 Prominent scapulae mimicking an inherited myopathy expands the phenotype of CHD7-related disease.Eur J Hum Genet. 2016 Aug;24(8):1216-9. doi: 10.1038/ejhg.2015.276. Epub 2016 Jan 27.
154 Recessive C10orf2 mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy.Neurogenetics. 2014 Aug;15(3):171-82. doi: 10.1007/s10048-014-0405-1. Epub 2014 May 10.
155 Myopathy in a 20-year-old female patient with D4ST-1 deficient Ehlers-Danlos syndrome due to a homozygous CHST14 mutation.Am J Med Genet A. 2012 Apr;158A(4):850-5. doi: 10.1002/ajmg.a.35232. Epub 2012 Mar 9.
156 Novel defects in collagen XII and VI expand the mixed myopathy/Ehlers-Danlos syndrome spectrum and lead to variant-specific alterations in the extracellular matrix.Genet Med. 2020 Jan;22(1):112-123. doi: 10.1038/s41436-019-0599-6. Epub 2019 Jul 5.
157 Cerebral small vessel disease with hemorrhagic stroke related to COL4A1 mutation: A case report.Neuropathology. 2020 Feb;40(1):93-98. doi: 10.1111/neup.12607. Epub 2019 Dec 5.
158 Reductive Stress Selectively Disrupts Collagen Homeostasis and Modifies Growth Factor-independent Signaling Through the MAPK/Akt Pathway in Human Dermal Fibroblasts.Mol Cell Proteomics. 2019 Jun;18(6):1123-1137. doi: 10.1074/mcp.RA118.001140. Epub 2019 Mar 19.
159 Type IX collagen gene mutations can result in multiple epiphyseal dysplasia that is associated with osteochondritis dissecans and a mild myopathy.Am J Med Genet A. 2010 Apr;152A(4):863-9. doi: 10.1002/ajmg.a.33240.
160 Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile.Eur J Hum Genet. 2019 Feb;27(2):331-335. doi: 10.1038/s41431-018-0286-0. Epub 2018 Oct 12.
161 Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.Acta Neuropathol. 2000 Jul;100(1):82-6. doi: 10.1007/s004010051196.
162 Zebrafish cysteine and glycine-rich protein 3 is essential for mechanical stability in skeletal muscles.Biochem Biophys Res Commun. 2019 Apr 9;511(3):604-611. doi: 10.1016/j.bbrc.2019.02.115. Epub 2019 Feb 28.
163 Myopathy with MTCYB mutation mimicking Multiple Acyl-CoA Dehydrogenase Deficiency.Rev Neurol (Paris). 2018 Dec;174(10):731-735. doi: 10.1016/j.neurol.2018.03.014. Epub 2018 Oct 11.
164 Depletion of the other genome-mitochondrial DNA depletion syndromes in humans.J Mol Med (Berl). 2002 Jul;80(7):389-96. doi: 10.1007/s00109-002-0343-5. Epub 2002 May 24.
165 Novel mutations in DNA2 associated with myopathy and mtDNA instability.Ann Clin Transl Neurol. 2019 Sep;6(9):1893-1899. doi: 10.1002/acn3.50888. Epub 2019 Sep 2.
166 DNAJB2 expression in normal and diseased human and mouse skeletal muscle.Am J Pathol. 2010 Jun;176(6):2901-10. doi: 10.2353/ajpath.2010.090663. Epub 2010 Apr 15.
167 Novel mutations in DNAJB6 cause LGMD1D and distal myopathy in French families.Eur J Neurol. 2018 May;25(5):790-794. doi: 10.1111/ene.13598. Epub 2018 Mar 30.
168 Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes.J Physiol. 1995 Mar 1;483 ( Pt 2)(Pt 2):299-306. doi: 10.1113/jphysiol.1995.sp020586.
169 Deficiency of emerin contributes differently to the pathogenesis of skeletal and cardiac muscles in LmnaH222P/H222P mutant mice.PLoS One. 2019 Aug 20;14(8):e0221512. doi: 10.1371/journal.pone.0221512. eCollection 2019.
170 Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: evidence for additional functions of EYS.Muscle Nerve. 2011 Oct;44(4):531-8. doi: 10.1002/mus.22115. Epub 2011 Aug 8.
171 Family of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis caused by a novel FAM111B mutation.J Dermatol. 2019 Nov;46(11):1014-1018. doi: 10.1111/1346-8138.15045. Epub 2019 Aug 7.
172 The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.J Clin Invest. 2007 Dec;117(12):3940-51. doi: 10.1172/JCI32741.
173 Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy. Eur J Hum Genet. 2014 Jul;22(7):902-6. doi: 10.1038/ejhg.2013.269. Epub 2013 Nov 27.
174 A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy.J Neurol Sci. 2019 Mar 15;398:75-78. doi: 10.1016/j.jns.2019.01.019. Epub 2019 Jan 17.
175 RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).Mol Ther. 2011 Nov;19(11):2048-54. doi: 10.1038/mt.2011.118. Epub 2011 Jul 5.
176 Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy.Nat Commun. 2019 Feb 15;10(1):797. doi: 10.1038/s41467-019-08548-9.
177 Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.Ann Neurol. 2017 Feb;81(2):227-239. doi: 10.1002/ana.24847. Epub 2017 Jan 27.
178 A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.Neuromuscul Disord. 1999 Oct;9(6-7):403-7. doi: 10.1016/s0960-8966(99)00040-1.
179 Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies.Neurol Sci. 2000;21(5 Suppl):S985-7. doi: 10.1007/s100720070017.
180 Iron-sulfur cluster biogenesis and human disease.Trends Genet. 2008 Aug;24(8):398-407. doi: 10.1016/j.tig.2008.05.008. Epub 2008 Jul 5.
181 Functional characterization of GYG1 variants in two patients with myopathy and glycogenin-1 deficiency. Neuromuscul Disord. 2019 Dec;29(12):951-960. doi: 10.1016/j.nmd.2019.10.002. Epub 2019 Oct 23.
182 Association between population structure and allele frequencies of the glycogen synthase 1 mutation in the Austrian Noriker draft horse.Anim Genet. 2017 Feb;48(1):108-112. doi: 10.1111/age.12481. Epub 2016 Aug 1.
183 Neuron-specific knockdown of Drosophila HADHB induces a shortened lifespan, deficient locomotive ability, abnormal motor neuron terminal morphology and learning disability.Exp Cell Res. 2019 Jun 15;379(2):150-158. doi: 10.1016/j.yexcr.2019.03.040. Epub 2019 Apr 3.
184 Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies.Curr Opin Rheumatol. 2013 Nov;25(6):735-41. doi: 10.1097/01.bor.0000434676.70268.66.
185 Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy. Hum Mol Genet. 2013 Jul 1;22(13):2590-602. doi: 10.1093/hmg/ddt107. Epub 2013 Mar 5.
186 Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.Sci Rep. 2018 Apr 4;8(1):5609. doi: 10.1038/s41598-018-23139-2.
187 A congenital myopathy with diaphragmatic weakness not linked to the SMARD1 locus.Neuromuscul Disord. 2007 Feb;17(2):174-9. doi: 10.1016/j.nmd.2006.11.002. Epub 2007 Jan 22.
188 Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.Hum Mol Genet. 2016 Dec 1;25(23):5178-5187. doi: 10.1093/hmg/ddw338.
189 Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology.Am J Pathol. 2002 Jun;160(6):2135-43. doi: 10.1016/s0002-9440(10)61162-5.
190 Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A.Invest Ophthalmol Vis Sci. 2005 Feb;46(2):530-9. doi: 10.1167/iovs.04-1125.
191 Impact of TIEG1 on the structural properties of fast- and slow-twitch skeletal muscle.Muscle Nerve. 2017 Mar;55(3):410-416. doi: 10.1002/mus.25252. Epub 2016 Dec 5.
192 Krppel-like factor 15: Regulator of BCAA metabolism and circadian protein rhythmicity.Pharmacol Res. 2018 Apr;130:123-126. doi: 10.1016/j.phrs.2017.12.018. Epub 2017 Dec 27.
193 Transcriptional upregulation of Bag3, a chaperone-assisted selective autophagy factor, in animal models of KY-deficient hereditary myopathy.Dis Model Mech. 2018 Jul 6;11(7):dmm033225. doi: 10.1242/dmm.033225.
194 Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160.Mol Ther Nucleic Acids. 2017 Mar 17;6:68-79. doi: 10.1016/j.omtn.2016.11.004. Epub 2016 Dec 10.
195 Increased polyamines as protective disease modifiers in congenital muscular dystrophy.Hum Mol Genet. 2018 Jun 1;27(11):1905-1912. doi: 10.1093/hmg/ddy097.
196 LIM and cysteine-rich domains 1 (LMCD1) regulates skeletal muscle hypertrophy, calcium handling, and force.Skelet Muscle. 2019 Oct 31;9(1):26. doi: 10.1186/s13395-019-0214-1.
197 Cardiometabolic assessment of lamin A/C gene mutation carriers: a phenotype-genotype correlation.Diabetes Metab. 2019 Sep;45(4):382-389. doi: 10.1016/j.diabet.2018.09.006. Epub 2018 Oct 1.
198 Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am J Hum Genet. 2008 Oct;83(4):489-94. doi: 10.1016/j.ajhg.2008.09.002. Epub 2008 Sep 25.
199 Overexpression of Latent TGF Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGF.PLoS Genet. 2016 May 5;12(5):e1006019. doi: 10.1371/journal.pgen.1006019. eCollection 2016 May.
200 Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.Sci Rep. 2018 Mar 6;8(1):4049. doi: 10.1038/s41598-018-21371-4.
201 Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.Hum Mol Genet. 2006 Jul 1;15(13):2087-97. doi: 10.1093/hmg/ddl132. Epub 2006 May 22.
202 Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat Genet. 2014 Feb;46(2):188-93. doi: 10.1038/ng.2851. Epub 2013 Dec 15.
203 MPV17-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects.Hum Mutat. 2018 Apr;39(4):461-470. doi: 10.1002/humu.23387. Epub 2018 Jan 13.
204 Whole-exome sequencing identifies rare compound heterozygous mutations in the MSTO1 gene associated with cerebellar ataxia and myopathy.Eur J Med Genet. 2020 Jan;63(1):103623. doi: 10.1016/j.ejmg.2019.01.013. Epub 2019 Jan 24.
205 Deficiency of MTMR14 impairs male fertility in Mus musculus.PLoS One. 2018 Nov 9;13(11):e0206224. doi: 10.1371/journal.pone.0206224. eCollection 2018.
206 Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.Hum Mol Genet. 2017 Oct 1;26(19):3736-3748. doi: 10.1093/hmg/ddx258.
207 Novel mutations in MYBPC1 are associated with myogenic tremor and mild myopathy.Ann Neurol. 2019 Jul;86(1):129-142. doi: 10.1002/ana.25494. Epub 2019 May 17.
208 Myosin binding protein C: implications for signal-transduction.J Muscle Res Cell Motil. 2012 May;33(1):31-42. doi: 10.1007/s10974-011-9281-6. Epub 2011 Dec 16.
209 Developmental MYH3 Myopathy Associated with Expression of Mutant Protein and Reduced Expression Levels of Embryonic MyHC.PLoS One. 2015 Nov 6;10(11):e0142094. doi: 10.1371/journal.pone.0142094. eCollection 2015.
210 Myosin VI localization and expression in striated muscle pathology.Anat Rec (Hoboken). 2014 Sep;297(9):1706-13. doi: 10.1002/ar.22967.
211 Distinct Muscle Biopsy Findings in Genetically Defined Adult-Onset Motor Neuron Disorders.PLoS One. 2016 Mar 21;11(3):e0151376. doi: 10.1371/journal.pone.0151376. eCollection 2016.
212 Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.FASEB J. 2019 Mar;33(3):3152-3166. doi: 10.1096/fj.201801402R. Epub 2018 Oct 26.
213 High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.J Clin Invest. 1998 May 15;101(10):2119-28. doi: 10.1172/JCI1505.
214 The role of AMP-activated protein kinase in the expression of the dystrophin-associated protein complex in skeletal muscle.FASEB J. 2018 Jun;32(6):2950-2965. doi: 10.1096/fj.201700868RRR. Epub 2018 Jan 11.
215 PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.J Hum Genet. 2017 Apr;62(5):525-529. doi: 10.1038/jhg.2016.163. Epub 2017 Jan 12.
216 Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance.Am J Hum Genet. 2008 Mar;82(3):652-60. doi: 10.1016/j.ajhg.2007.12.012. Epub 2008 Feb 14.
217 The potential of obscurin as a therapeutic target in muscle disorders.Expert Opin Ther Targets. 2017 Sep;21(9):897-910. doi: 10.1080/14728222.2017.1361931. Epub 2017 Aug 4.
218 Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex.Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2908-13. doi: 10.1073/pnas.0913736107. Epub 2010 Feb 1.
219 Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.Neuropathol Appl Neurobiol. 2013 Jun;39(4):406-16. doi: 10.1111/j.1365-2990.2012.01297.x.
220 Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene.Neuromuscul Disord. 2016 Jul;26(7):436-40. doi: 10.1016/j.nmd.2016.05.001. Epub 2016 May 5.
221 Autosomal dominant Brody disease cosegregates with a chromosomal (2;7)(p11.2;p12.1) translocation in an Italian family.Eur J Hum Genet. 2004 Jul;12(7):579-83. doi: 10.1038/sj.ejhg.5201200.
222 Biallelic variants in the transcription factor PAX7 are a new genetic cause of myopathy. Genet Med. 2019 Nov;21(11):2521-2531. doi: 10.1038/s41436-019-0532-z. Epub 2019 May 16.
223 Poly(C)-binding protein 1 (Pcbp1) regulates skeletal muscle differentiation by modulating microRNA processing in myoblasts.J Biol Chem. 2017 Jun 9;292(23):9540-9550. doi: 10.1074/jbc.M116.773671. Epub 2017 Apr 5.
224 Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography.J Neurol Sci. 2012 Jul 15;318(1-2):163-7. doi: 10.1016/j.jns.2012.04.007. Epub 2012 Apr 27.
225 Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.Parkinsonism Relat Disord. 2019 Jul;64:319-323. doi: 10.1016/j.parkreldis.2019.04.004. Epub 2019 Apr 5.
226 Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A. 2005 Feb 15;133A(1):82-4. doi: 10.1002/ajmg.a.30517.
227 Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in PHOX2A.Brain. 2006 Sep;129(Pt 9):2363-74. doi: 10.1093/brain/awl161. Epub 2006 Jun 30.
228 Distal myopathy.Tohoku J Exp Med. 1990 Aug;161 Suppl:1-19. doi: 10.1620/tjem.161.supplement_1.
229 Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse.Hum Mol Genet. 2009 Oct 1;18(19):3553-66. doi: 10.1093/hmg/ddp304. Epub 2009 Jul 4.
230 Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.Neuromuscul Disord. 2017 May;27(5):481-486. doi: 10.1016/j.nmd.2017.01.011. Epub 2017 Jan 17.
231 Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2.J Neurol. 2010 Sep;257(9):1517-23. doi: 10.1007/s00415-010-5565-9. Epub 2010 Apr 20.
232 Clinical, histological, and genetic characterization of PYROXD1-related myopathy.Acta Neuropathol Commun. 2019 Aug 27;7(1):138. doi: 10.1186/s40478-019-0781-8.
233 Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.Biochem Biophys Res Commun. 2004 Oct 1;322(4):1256-66. doi: 10.1016/j.bbrc.2004.08.031.
234 Stable reference genes for expression studies in breast muscle of normal and white striping-affected chickens.Mol Biol Rep. 2020 Jan;47(1):45-53. doi: 10.1007/s11033-019-05103-z. Epub 2019 Oct 3.
235 Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies.Eur J Neurol. 2018 Jun;25(6):841-847. doi: 10.1111/ene.13607. Epub 2018 Mar 26.
236 Post-transcriptional control of selenoprotein biosynthesis.Curr Protein Pept Sci. 2012 Jun;13(4):337-46. doi: 10.2174/138920312801619448.
237 SELENON (SEPN1) protects skeletal muscle from saturated fatty acid-induced ER stress and insulin resistance.Redox Biol. 2019 Jun;24:101176. doi: 10.1016/j.redox.2019.101176. Epub 2019 Mar 23.
238 SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy.J Mol Cell Cardiol. 2015 Jan;78:154-64. doi: 10.1016/j.yjmcc.2014.08.003. Epub 2014 Aug 12.
239 Inflammatory myopathy in scapulo-ilio-peroneal atrophy with cardiopathy. A study of two families.Brain. 1975 Dec;98(4):709-22. doi: 10.1093/brain/98.4.709.
240 SIL1, the endoplasmic-reticulum-localized BiP co-chaperone, plays a crucial role in maintaining skeletal muscle proteostasis and physiology.Dis Model Mech. 2018 May 10;11(5):dmm033043. doi: 10.1242/dmm.033043.
241 Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice.PLoS One. 2017 Mar 9;12(3):e0173708. doi: 10.1371/journal.pone.0173708. eCollection 2017.
242 Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy.Eur J Hum Genet. 2015 Jan;23(1):67-71. doi: 10.1038/ejhg.2014.58. Epub 2014 Apr 23.
243 Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.Muscle Nerve. 2005 Sep;32(3):303-9. doi: 10.1002/mus.20362.
244 The lethal hemolytic mutation in beta I sigma 2 spectrin Providence yields a null phenotype in neonatal skeletal muscle.Lab Invest. 1996 Jun;74(6):1117-29.
245 A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness.Hum Genet. 2017 Jul;136(7):903-910. doi: 10.1007/s00439-017-1814-7. Epub 2017 May 24.
246 Interstitial 3p25.3-p26.1 deletion in a patient with intellectual disability.Am J Med Genet A. 2012 Oct;158A(10):2587-90. doi: 10.1002/ajmg.a.35562. Epub 2012 Sep 10.
247 STAC proteins associate to the IQ domain of Ca(V)1.2 and inhibit calcium-dependent inactivation.Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1376-1381. doi: 10.1073/pnas.1715997115. Epub 2018 Jan 23.
248 Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization.PLoS Genet. 2014 Sep 11;10(9):e1004605. doi: 10.1371/journal.pgen.1004605. eCollection 2014 Sep.
249 Nesprin-1/2: roles in nuclear envelope organisation, myogenesis and muscle disease.Biochem Soc Trans. 2018 Apr 17;46(2):311-320. doi: 10.1042/BST20170149. Epub 2018 Feb 27.
250 Advances in primary mitochondrial myopathies.Curr Opin Neurol. 2019 Oct;32(5):715-721. doi: 10.1097/WCO.0000000000000743.
251 Biallelic Mutations in TMEM126B Cause Severe Complex I Deficiency with a Variable Clinical Phenotype.Am J Hum Genet. 2016 Jul 7;99(1):217-27. doi: 10.1016/j.ajhg.2016.05.021. Epub 2016 Jun 30.
252 TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy. Ann Neurol. 2011 Jun;69(6):1005-13. doi: 10.1002/ana.22338. Epub 2011 Mar 9.
253 Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation.Arch Dis Child. 2010 Apr;95(4):296-301. doi: 10.1136/adc.2009.168096.
254 The loss of slow skeletal muscle isoform of troponin T in spindle intrafusal fibres explains the pathophysiology of Amish nemaline myopathy.J Physiol. 2019 Aug;597(15):3999-4012. doi: 10.1113/JP278119. Epub 2019 Jul 3.
255 A new family with transportinopathy: increased clinical heterogeneity.Ther Adv Neurol Disord. 2019 Jun 9;12:1756286419850433. doi: 10.1177/1756286419850433. eCollection 2019.
256 Compound heterozygous mutations of the TNXB gene cause primary myopathy.Neuromuscul Disord. 2013 Aug;23(8):664-9. doi: 10.1016/j.nmd.2013.04.009. Epub 2013 Jun 12.
257 1q21.3 deletion involving GATAD2B: An emerging recurrent microdeletion syndrome.Am J Med Genet A. 2017 Mar;173(3):766-770. doi: 10.1002/ajmg.a.38082.
258 New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations.Hum Mol Genet. 2015 Jul 1;24(13):3638-50. doi: 10.1093/hmg/ddv108. Epub 2015 Mar 23.
259 Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification.J Mol Cell Biol. 2019 May 1;11(5):356-370. doi: 10.1093/jmcb/mjy036.
260 Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.J Neuropathol Exp Neurol. 2011 Apr;70(4):302-13. doi: 10.1097/NEN.0b013e31821350b0.
261 COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.Am J Hum Genet. 2019 May 2;104(5):847-860. doi: 10.1016/j.ajhg.2019.03.007.
262 Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy.Neuromuscul Disord. 2000 Dec;10(8):572-7. doi: 10.1016/s0960-8966(00)00150-4.
263 Titin mutations and muscle disease.Pflugers Arch. 2019 May;471(5):673-682. doi: 10.1007/s00424-019-02272-5. Epub 2019 Mar 27.